Immuneering Corporation (IMRX) Misses Q4 EPS by 13c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| ImaRx Therapeutics, Inc. (NASDAQ: IMRX) | Delayed: 3.80 +0.06 (1.60%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.74 | 52 Week High | $0.04 | |||
| Open | $3.72 | 52 Week Low | $0.00 | |||
| Day High | $3.84 | P/E | N/A | |||
| Day Low | $3.70 | EPS | $-0.09 | |||
| Volume | 220,689 | |||||
